Logo image of ACAN.PA

ACANTHE DEVELOPPEMENT SA (ACAN.PA) Stock Fundamental Analysis

EPA:ACAN - Euronext Paris - Matif - FR0000064602 - REIT - Currency: EUR

0.333  0 (-0.6%)

Fundamental Rating

3

Taking everything into account, ACAN scores 3 out of 10 in our fundamental rating. ACAN was compared to 40 industry peers in the Diversified REITs industry. While ACAN has a great health rating, there are worries on its profitability. ACAN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ACAN has reported negative net income.
In the past year ACAN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ACAN reported negative net income in multiple years.
Of the past 5 years ACAN 4 years had a positive operating cash flow.
ACAN.PA Yearly Net Income VS EBIT VS OCF VS FCFACAN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

The Return On Assets of ACAN (-2.99%) is worse than 87.50% of its industry peers.
ACAN's Return On Equity of -3.54% is on the low side compared to the rest of the industry. ACAN is outperformed by 82.50% of its industry peers.
With a Return On Invested Capital value of 0.54%, ACAN is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -2.99%
ROE -3.54%
ROIC 0.54%
ROA(3y)-2.84%
ROA(5y)-1.12%
ROE(3y)-3.39%
ROE(5y)-1.48%
ROIC(3y)N/A
ROIC(5y)N/A
ACAN.PA Yearly ROA, ROE, ROICACAN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

The Operating Margin of ACAN (23.36%) is worse than 80.00% of its industry peers.
In the last couple of years the Operating Margin of ACAN has grown nicely.
ACAN's Gross Margin of 73.83% is in line compared to the rest of the industry. ACAN outperforms 50.00% of its industry peers.
In the last couple of years the Gross Margin of ACAN has remained more or less at the same level.
Industry RankSector Rank
OM 23.36%
PM (TTM) N/A
GM 73.83%
OM growth 3YN/A
OM growth 5Y106.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-1.25%
ACAN.PA Yearly Profit, Operating, Gross MarginsACAN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600 800

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACAN is destroying value.
The number of shares outstanding for ACAN has been increased compared to 1 year ago.
Compared to 5 years ago, ACAN has more shares outstanding
Compared to 1 year ago, ACAN has a worse debt to assets ratio.
ACAN.PA Yearly Shares OutstandingACAN.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ACAN.PA Yearly Total Debt VS Total AssetsACAN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

ACAN has an Altman-Z score of 2.70. This is not the best score and indicates that ACAN is in the grey zone with still only limited risk for bankruptcy at the moment.
ACAN's Altman-Z score of 2.70 is amongst the best of the industry. ACAN outperforms 97.50% of its industry peers.
ACAN has a debt to FCF ratio of 0.87. This is a very positive value and a sign of high solvency as it would only need 0.87 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.87, ACAN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that ACAN is not too dependend on debt financing.
ACAN has a better Debt to Equity ratio (0.01) than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.87
Altman-Z 2.7
ROIC/WACC0.07
WACC7.81%
ACAN.PA Yearly LT Debt VS Equity VS FCFACAN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 2.11 indicates that ACAN has no problem at all paying its short term obligations.
ACAN has a better Current ratio (2.11) than 92.50% of its industry peers.
ACAN has a Quick Ratio of 2.11. This indicates that ACAN is financially healthy and has no problem in meeting its short term obligations.
ACAN has a Quick ratio of 2.11. This is amongst the best in the industry. ACAN outperforms 92.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 2.11
ACAN.PA Yearly Current Assets VS Current LiabilitesACAN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 66.08% over the past year.
Looking at the last year, ACAN shows a decrease in Revenue. The Revenue has decreased by -1.16% in the last year.
The Revenue has been decreasing by -6.49% on average over the past years.
EPS 1Y (TTM)66.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.35%
Revenue 1Y (TTM)-1.16%
Revenue growth 3Y0.44%
Revenue growth 5Y-6.49%
Sales Q2Q%-1.42%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACAN.PA Yearly Revenue VS EstimatesACAN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

0

4. Valuation

4.1 Price/Earnings Ratio

ACAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACAN.PA Price Earnings VS Forward Price EarningsACAN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACAN indicates a slightly more expensive valuation: ACAN is more expensive than 77.50% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 38.08
EV/EBITDA N/A
ACAN.PA Per share dataACAN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ACAN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ACANTHE DEVELOPPEMENT SA

EPA:ACAN (7/1/2025, 7:00:00 PM)

0.333

0 (-0.6%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)04-23 2025-04-23
Earnings (Next)09-22 2025-09-22
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners49.25%
Ins Owner ChangeN/A
Market Cap55.06M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.02
Dividend Growth(5Y)-46.74%
DP-70.88%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 14.04
P/FCF 38.08
P/OCF 36.37
P/B 0.49
P/tB 0.49
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY2.63%
OCF(TTM)0.01
OCFY2.75%
SpS0.02
BVpS0.68
TBVpS0.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.99%
ROE -3.54%
ROCE 0.74%
ROIC 0.54%
ROICexc 0.57%
ROICexgc 0.57%
OM 23.36%
PM (TTM) N/A
GM 73.83%
FCFM 36.88%
ROA(3y)-2.84%
ROA(5y)-1.12%
ROE(3y)-3.39%
ROE(5y)-1.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y110.88%
ROICexc growth 3YN/A
ROICexc growth 5Y110.88%
OM growth 3YN/A
OM growth 5Y106.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-1.25%
F-Score5
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.87
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1.73%
Interest Coverage 250
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.11
Quick Ratio 2.11
Altman-Z 2.7
F-Score5
WACC7.81%
ROIC/WACC0.07
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)3.26%
Cap/Sales(5y)6.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.35%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.16%
Revenue growth 3Y0.44%
Revenue growth 5Y-6.49%
Sales Q2Q%-1.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y110.94%
EBIT growth 3YN/A
EBIT growth 5Y93.23%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-65.58%
FCF growth 3YN/A
FCF growth 5Y20.72%
OCF growth 1Y-65.3%
OCF growth 3YN/A
OCF growth 5Y-16.48%